Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Granoff

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Plos One|March 31, 2012
Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activitySerena Giuntini, Peter T Beernink, Donald C Reason, et al.
Infection and Immunity|April 2, 2014
Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat modelLisa A Lewis, David M Vu, Dan M Granoff, et al.
Scientific Reports|March 31, 2012
A broadly cross-reactive monoclonal antibody against an epitope on the n-terminus of meningococcal fHbpDavid M Vu, Rolando Pajon, Donald C Reason, et al.
Vaccine|January 2, 2010
Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolatesRolando Pajon, Peter T Beernink, Lee H Harrison, et al.
Infection and Immunity|October 16, 2002
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strainsGregory R Moe, Patricia Zuno-Mitchell, Samantha N Hammond, et al.
Vaccine|June 28, 2017
The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4CElizabeth Partridge, Eduardo Lujan, Serena Giuntini, et al.
Clinical and Vaccine Immunology : CVI|September 5, 2014
Heterogeneity in rhesus macaque complement factor H binding to meningococcal factor H binding protein (FHbp) informs selection of primates to assess immunogenicity of FHbp-based vaccinesPeter T Beernink, Jutamas Shaughnessy, Heather Stefek, et al.
Lancet (London, England)|June 6, 2003
Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countriesLuis Jódar, F Marc LaForce, Costante Ceccarini, et al.
Mbio|June 25, 2015
Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding ProteinPeter T Beernink, Serena Giuntini, Isabella Costa, et al.
Plos Neglected Tropical Diseases|September 13, 2011
Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine developmentRolando Pajon, Andrew M Fergus, Oliver Koeberling, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Plos One|March 31, 2012
Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activitySerena Giuntini, Peter T Beernink, Donald C Reason, et al.
Infection and Immunity|April 2, 2014
Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat modelLisa A Lewis, David M Vu, Dan M Granoff, et al.
Scientific Reports|March 31, 2012
A broadly cross-reactive monoclonal antibody against an epitope on the n-terminus of meningococcal fHbpDavid M Vu, Rolando Pajon, Donald C Reason, et al.
Vaccine|January 2, 2010
Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolatesRolando Pajon, Peter T Beernink, Lee H Harrison, et al.
Infection and Immunity|October 16, 2002
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strainsGregory R Moe, Patricia Zuno-Mitchell, Samantha N Hammond, et al.
Vaccine|June 28, 2017
The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4CElizabeth Partridge, Eduardo Lujan, Serena Giuntini, et al.
Clinical and Vaccine Immunology : CVI|September 5, 2014
Heterogeneity in rhesus macaque complement factor H binding to meningococcal factor H binding protein (FHbp) informs selection of primates to assess immunogenicity of FHbp-based vaccinesPeter T Beernink, Jutamas Shaughnessy, Heather Stefek, et al.
Lancet (London, England)|June 6, 2003
Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countriesLuis Jódar, F Marc LaForce, Costante Ceccarini, et al.
Mbio|June 25, 2015
Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding ProteinPeter T Beernink, Serena Giuntini, Isabella Costa, et al.
Plos Neglected Tropical Diseases|September 13, 2011
Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine developmentRolando Pajon, Andrew M Fergus, Oliver Koeberling, et al.
Pageof 10